Skip to main content

The context you need, when you need it

When news breaks, you need to understand what actually matters — and what to do about it. At Vox, our mission to help you make sense of the world has never been more vital. But we can’t do it on our own.

We rely on readers like you to fund our journalism. Will you support our work and become a Vox Member today?

Join now

Amazon’s entry into the health care industry, by the numbers

This could be Amazon’s biggest challenge yet.

Amazon CEO Jeff Bezos inside the new Amazon Spheres
Amazon CEO Jeff Bezos inside the new Amazon Spheres
Amazon CEO Jeff Bezos inside the new Amazon Spheres
Jason Redmond/AFP/Getty Images
Rani Molla
Rani Molla was a senior correspondent at Vox and has been focusing her reporting on the future of work. She has covered business and technology for more than a decade — often in charts — including at Bloomberg and the Wall Street Journal.

Amazon is no stranger to disrupting industries. But with its tentative entrance into health care, along with Berkshire Hathaway and JPMorgan Chase, it might have challenged its biggest industry yet.

When Amazon announced today that it might be starting its own health care company, health care stocks, predictably, fell. Health services and health technology sectors declined more than any others in the Dow Jones Industrial Average today.

Health insurance companies like UnitedHealth suffered the worst, followed by pharmaceutical companies like Pfizer.

These declines aren’t disastrous by any means. The thing is, the health care industry is huge and any disruption in the industry could have far-reaching effects on Americans. Spending on health care accounts for nearly 20 percent of the U.S. GDP. Health care is also now the biggest employer in the U.S.

Health care companies — especially pharmaceutical and biotech companies — have huge profit margins, especially compared to Amazon. The Amazon, Berkshire Hathaway and JPMorgan Chase consortium could make a dent in those as it tries to reduce costs “through an independent company that is free from profit-making incentives and constraints.”

And Amazon, Berkshire and JPMorgan are huge and have plenty of technology know-how they could bring to bear on the health care industry. Check out their market cap compared to the biggest U.S. health care companies.

For now, Amazon et al. are only hoping to roll out this health care company to their employees. The real threat to other health care companies would be if Amazon decided to eventually roll out this program more broadly.

As Barclay’s analysts noted today, “we are never dismissive of anything disruptive that Amazon is involved in.”


This article originally appeared on Recode.net.

More in Technology

Podcasts
Are humanoid robots all hype?Are humanoid robots all hype?
Podcast
Podcasts

AI is making them better — but they’re not going to be doing your chores anytime soon.

By Avishay Artsy and Sean Rameswaram
Future Perfect
The old tech that could help stop the next airborne pandemicThe old tech that could help stop the next airborne pandemic
Future Perfect

Glycol vapors, explained.

By Shayna Korol
Future Perfect
Elon Musk could lose his case against OpenAI — and still get what he wantsElon Musk could lose his case against OpenAI — and still get what he wants
Future Perfect

It’s not about who wins. It’s about the dirty laundry you air along the way.

By Sara Herschander
Life
Why banning kids from AI isn’t the answerWhy banning kids from AI isn’t the answer
Life

What kids really need in the age of artificial intelligence.

By Anna North
Culture
Anthropic owes authors $1.5B for pirating work — but the claims process is a Kafkaesque messAnthropic owes authors $1.5B for pirating work — but the claims process is a Kafkaesque mess
Culture

“Your AI monster ate all our work. Now you’re trying to pay us off with this piece of garbage that doesn’t work.”

By Constance Grady
Future Perfect
Some deaf children are hearing again because of a new gene therapySome deaf children are hearing again because of a new gene therapy
Future Perfect

A medical field that almost died is quietly fixing one disease at a time.

By Bryan Walsh